Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,569,008
+$726,171 QoQ
Shares Held
43,021
+1.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#452
of 2,602 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $85,439,394 across 8 Diagnostics & Research names. TMO ranks #3 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
158,423 | $30,176,413 | |
| 2 | LH |
Labcorp Holdings Inc.
|
85,568 | $23,959,040 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
This page
|
43,021 | $21,569,008 | |
| 4 | ILMN |
Illumina, Inc.
|
28,137 | $4,947,328 | |
| 5 | VCYT |
Veracyte, Inc.
|
62,229 | $3,654,709 | |
| 6 | MYGN |
Myriad Genetics Inc
|
81,392 | $464,748 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,494 | $464,108 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,056 | $204,040 |
All Filings in TMO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,569,008 | 43,021 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $20,842,837 | 42,404 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,106,409 | 43,328 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,171,607 | 43,651 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,739,010 | 41,284 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,618,056 | 41,435 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $20,658,853 | 39,711 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $28,289,061 | 45,733 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,394,841 | 40,497 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,249,037 | 36,560 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $17,992,719 | 33,898 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $17,086,274 | 33,756 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,222,967 | 33,010 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $18,483,033 | 32,068 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,929,862 | 30,743 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,545,880 | 30,651 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,934,580 | 31,171 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,518,679 | 29,660 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $19,260,549 | 28,866 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $16,059,514 | 28,109 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,952,126 | 27,657 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,779,338 | 34,575 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,629,366 | 42,143 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,431,051 | 7,771 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||